Dexmedetomidine-ketamine Combination Versus Fentanyl-midazolam During Bronchoscopy

PHASE3CompletedINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

September 1, 2019

Primary Completion Date

May 31, 2020

Study Completion Date

August 31, 2020

Conditions
Lung DiseasesDiagnosisAnesthesia
Interventions
DRUG

Dexmedetomidine

Dexmedetomidine solution of 1 μg/kg dissolved in 60 ml saline was administered over 15 minutes, followed by a maintenance dose of 0.5 μg/kg/h (continuous infusion).

DRUG

Ketamine

A bolus dose of 50 mg ketamine dissolved in 10 ml saline was given 15 minutes after Dexmedetomidine initiation.

DRUG

Midazolam

Bolus doses of midazolam (5 mg midazolam dissolved in 10 ml saline; 2 ml of the solution or 1 mg midazolam per bolus, premedication dose of 2mg, induction dose of 2 mg) were administered at 20-minute intervals in between and titrated as needed to obtain the desired sedation depth. No more than 12 mg of midazolam were administered.

DRUG

Fentanyl

Bolus doses of fentanyl (100 μg / 10 ml; 5 ml of the solution or 50 μg fentanyl per bolus, induction dose of 50μg) were administered at 20-minute intervals in between and titrated as needed to obtain the desired sedation depth. No more than 150 μg of fentanyl were administered.

Trial Locations (1)

15561

Naval Hospital, Athens

All Listed Sponsors
lead

University of Patras

OTHER

NCT06185127 - Dexmedetomidine-ketamine Combination Versus Fentanyl-midazolam During Bronchoscopy | Biotech Hunter | Biotech Hunter